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Abstract
Mutations in retinitis pigmentosa GTPase regulator (RPGR) cause severe retinal ciliopathy, X-linked retinitis pigmentosa.
Although two major alternatively spliced isoforms, RPGRex1-19 and RPGRORF15, are expressed, the relative importance of
these isoforms in disease pathogenesis is unclear. Here, we analyzed fibroblast samples from eight patients and found that
all of them form longer cilia than normal controls, albeit to different degrees. Although all mutant RPGRORF15 messenger
RNAs (mRNAs) are unstable, their steady-state levels were similar or higher than those in the control cells, suggesting there
may be increased transcription. Three of the fibroblasts that had higher levels of mutant RPGRORF15 mRNA also exhibited
significantly higher levels of RPGRex1-19 mRNA. Four samples with unaltered RPGRex1-19 levels carried mutations in
RPGRORF15 that resulted in this isoform being relatively less stable. Thus, in all cases, the RPGRex1-19/RPGRORF15 isoform ratio
was increased, and this was highly correlative to the cilia extension defect. Moreover, overexpression of RPGRex1-19
(mimicking the increase in RPGRex1-19 to RPGRORF15 isoform ratio) or RPGRORF15 (mimicking reduction of the ratio) resulted
in significantly longer or shorter cilia, respectively. Notably, the cilia length defect appears to be attributable to both the loss
of the wild-type RPGRORF15 protein and to the higher levels of the RPGRex1-19 isoform, indicating that the observed defect is
due to the altered isoform ratios. These results suggest that maintaining the optimal RPGRex1-9 to RPGRORF15 ratio is critical
for cilia growth and that designing strategies that focus on the best ways to restore the RPGRex1-19/RPGRORF15 ratio may lead
to better therapeutic outcomes.
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Introduction
Primary cilia are evolutionarily conserved microtubule-based
non-motile protrusions of the plasma membrane of most ver-
tebrate cell types (1). They are nucleated from the basal bod-
ies (mother centrioles) that dock at the apical plasma mem-
brane in quiescent cells. The proximal region of the cilia, also
called transition zone, acts as a gate. The microtubules further
extend to form a distal axoneme surrounded by the ciliary mem-
brane. The primary cilium regulates critical developmental and
homeostatic signaling cascades by targeting several integral and
peripheral membrane proteins as well as soluble moieties along
the axoneme via a conserved mechanism termed intraflagel-
lar transport (2,3). The trafficking is also regulated by macro-
molecular complexes of several proteins including retinitis pig-
mentosa GTPase regulator (RPGR), centrosomal protein 290 kDa
(CEP290), centrosomal protein 110 kDa (CP110), Usher Syndrome
proteins and Bardet Biedl Syndrome proteins (4,5). Mutations in
these proteins are associated with severe developmental and
homeostatic disorders collectively termed ciliopathies (6). These
include Meckel–Gruber Syndrome, Joubert Syndrome, Senior–
Loken Syndrome, Usher Syndrome and some forms of non-
syndromic photoreceptor degenerations.
Photoreceptors (rods and cones) have a modified sensory
cilium in the form of the light-sensing outer segment. The pho-
toreceptors are one of the highly metabolically active cell types
in the body. They depend upon stringently controlled proteins
and lipid trafficking from their site of synthesis in the inner seg-
ment to the outer segment for light detection (7). Perturbations
in the trafficking machinery due to functional deficits in ciliary
proteins lead to severe photoreceptor degeneration (2,3,8). One
such ciliary trafficking regulator is RPGR.
Mutations in RPGR are associated with X-linked forms of
retinitis pigmentosa (RP), a debilitating blindness characterized
by severe and progressive photoreceptor degeneration (9–12).
RPGR mutations account for the majority (∼70%) of X-linked
retinitis pigmentosa (XLRP) cases and 12–15% of simplex RP,
with no family history (12–14). In addition, RPGR mutations are
associated with cone–rod degeneration, macular dystrophy and
extraocular presentations, such as sperm abnormalities, hearing
defects and primary cilia dyskinesia (15–19). Overall, RPGR muta-
tions are a leading cause of blindness accounting for almost 20%
of all RP cases.
The RPGR gene encodes two major alternatively spliced iso-
forms: RPGRex1-19 (19 exons) and RPGRORF15 (terminating in intron
15; exon ORF15) (20–23). The terminal exon 19 of the RPGRex1-19
isoform carries an isoprenylation signal involved in its localiza-
tion to cilia (24,25). Exon ORF15 of the RPGRORF15 isoform contains
purine-rich repeats that encode for a glutamic acid and glycine-
rich domain (26). As majority of RPGR mutations are located
in exon ORF15, the RPGRORF15 isoform has been considered the
major disease-associated isoform in humans (26). The great
majority of exon ORF15 mutations are predicted to prematurely
truncate the RPGRORF15 protein.
Both RPGR isoforms are expressed throughout the body, but
are particularly abundant in the retina. Previous studies have
identified mouse and canine models of RPGR mutations and
have suggested the involvement of RPGR in regulating ciliary
trafficking by acting as a gatekeeper at the transition zone
(27–31). Loss of RPGR alters protein trafficking to the photorecep-
tor outer segment, but permits its initial generation. RPGR deple-
tion alters cilia length in cultured cell lines and fibroblasts (32).
However, the effect on the ciliary defects of different RPGRORF15
mutations is unclear.
To investigate the effect of the human disease-causing
mutations in RPGRORF15 on its expression and on cilia formation,
we analyzed RPGR isoform expression, cilia formation and
ciliary protein trafficking in patient-derived cells. Our studies
unravel a new potential pathogenic mechanism of RPGRORF15
disease, which may assist in developing new therapies for these
conditions.
Results
Ciliary defects in RPGRORF15-mutant fibroblasts
Given that RPGR regulates cilia length (32), we examined cilia
formation in the patient and control fibroblasts. We generated
primary fibroblasts from skin biopsy specimens from eight male
RPGRORF15 patients (RPGR-1, RPGR-2, RPGR-3, RPGR-4, RPGR-5,
RPGR-6, RPGR-7 and RPGR-8) with frameshift and truncation
mutations in exon ORF15 (Fig. 1A and B). The patients were all
from families previously confirmed to have X-linked RP due to
RPGRORF15 mutations (33,34); their ages at skin biopsy ranged from
21 to 66 years. The patients had ophthalmoscopic features of
pigmentary retinopathy, abnormal visual fields and reduced or
non-detectable electroretinograms (33,34). As the control sam-
ples from the same family members could not be obtained, we
included six random asymptomatic control samples without
RPGR mutations (CTL-1, CTL-2, CTL-3, CTL-4, CTL-5 and CTL-6).
Although the control and RPGR-2 fibroblasts grew cilia in
the range of 1–1.5 μm, we detected two groups of mutations
with longer cilia: cilia were elongated to a range of 2.5–3.5 μm
range in the RPGR-1, RPGR-3, RPGR-4 and RPGR-5 fibroblasts and
to a lesser extent (1.8–2.5 μm) in RPGR-6, RPGR-7 and RPGR-8
(Fig. 2A and B). As predicted, we did not detect an effect on the
number of ciliated cells.
Correlation of cilia length to RPGR isoform levels in
fibroblasts
We next asked whether the observed ciliary phenotype was
associated with an effect of exon ORF15 mutations on RPGR
expression. To this end, we performed quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) analysis of
the two major isoforms. We found significantly higher levels
(8–10-fold) of the RPGRex1-19 isoform in RPGR-3, RPGR-4 and RPGR-
5 fibroblasts samples when compared with the other RPGR
mutants or the control fibroblasts (Fig. 3A). We also detected
higher levels (2–3-fold) of the mutant RPGRORF15 isoform in RPGR-
3, RPGR-4 and RPGR-5. Interestingly, the level of the mutant
RPGRORF15 in RPGR-1 was significantly reduced when compared
with the controls (Fig. 3B).
Given that RPGR-1, RPGR-3, RPGR-4 and RPGR-5 also
formed relatively longer cilia, we tested whether there was
a correlation between the RPGRex1-19/RPGRORF15 ratio and the
cilia length. Although the RPGR-2, RPGR-6, RPGR-7, RPGR-8
and control fibroblasts showed an RPGRex1-19/RPGRORF15 ratio of
∼10-fold, in RPGR-1, RPGR-3, RPGR-4 and RPGR-5 fibroblasts,
there was an increased ratio of between 18- and 35-fold
(Fig. 3C). Furthermore, we found that the length of the cilia
was highly correlative to RPGRex1-19/RPGRORF15 ratio, with the
coefficient of determination (R2) of ∼83% (Fig. 3D). Using
RPGR isoform-specific antibodies (Supplementary Fig. S1A),
we also detected a significant increase (18–20-fold) in the
ratio of the RPGRex1-19/RPGRORF15 protein levels in RPGR-1,
RPGR-3, RPGR-4 and RPGR-5 when compared with other
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Figure 1. RPGRORF15 mutations. Schematic representation (A) and predicted effect of RPGRORF15 mutations (B) in XLRP patients. ∗ : optic cups of RPGR-3 were generated.
Figure 2. Ciliary defects in fibroblasts. (A) Control (CTL-1 and CTL-2) and mutant fibroblasts were stained for acetylated α-tubulin (red, ciliary marker) and 4′ ,6-
diamidino-2-phenylindole (DAPI) (blue, nucleus). Scale: 5 μm. (B) The cilia length was quantified using the ImageJ software (n > 100). The CTL data represents the
average cilia length of all control fibroblasts. ∗∗∗∗P < 0.0001; ∗∗∗P < 0.002; ∗∗P < 0.01; ∗P < 0.05.
We then checked whether such phenomenon of increased
RPGRex1-19/RPGRORF15 ratio is also conserved in retinal microenvi-
ronment. Using retinal organoids derived from reprogrammed
control and RPGR-3 human-induced pluripotent stem cells
(iPSCs; Supplementary Fig. S2A and B) (West et al. 2020,
manuscript submitted), we found significant (∼2.8-fold) increase
in the RPGRex1-19/RPGRORF15 ratio in the mutant sample as
compared with the controls (Supplementary Fig. S2C).
These results suggest that RPGRORF15 mutations tested in this
study affect not only mutant RPGRORF15 expression levels but also
the RPGRex1-19 isoform levels, albeit to different extents. Although
in fibroblast samples from all RPGR patients there was a posi-
tive correlation between the RPGRex1-19/RPGRORF15 ratio and cilia
length, in RPGR-1, RPGR-3, RPGR-4 and RPGR-5 samples, there
were distinct effects on the RPGR messenger RNA (mRNA) levels.
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Figure 3. RPGR isoform levels in patient-derived fibroblasts. (A, B) RPGRex1-19 (A) or RPGRORF15 levels in the mutant fibroblasts relative to controls (CTL) were analyzed.
(C) The ratio of RPGRex1-19 to RPGRORF15 mRNA levels was determined. RPGR-1, RPGR-3, RPGR-4 and RPGR-5 showed significantly higher ratio when compared with control
(CTL) cells. ns, not significant. Data are mean ± SD from five independent experiments. (D) Positive correlation of the cilium length with the RPGRex1-19/RPGRORF15 ratio
was observed. Each dot represents average cilium length of >100 cilia compared with the RPGRex1-19/RPGRORF15 ratio from three independent experiments. Black line
shows a linear fit through the data. Inset displays the coefficient of determination (R2) and significance (P-value).
RPGRORF15 expression, but does not affect the RPGRex1-19 levels. On
the other hand, although the mutant RPGRORF15 is expressed at
relatively higher levels in RPGR-3, RPGR-4 and RPGR-5 fibroblast
samples, they exhibit significantly higher levels of RPGRex1-19. To
further understand the ciliary defects, we focused on RPGR-1,
RPGR-3, RPGR-4 and RPGR-5 samples. We also used RPGR-2 as
it showed similar RPGR expression as the control fibroblasts.
Localization of cilia length regulators in
RPGRORF15-mutant fibroblasts
To investigate the ciliary defect in the fibroblasts with elongated
cilia, we assessed the distribution of ciliary length regulators
CEP290 and distribution of glutamylated tubulin. CEP290 muta-
tions are a frequent cause of Leber congenital amaurosis and
syndromic ciliopathies (35–37). Immunofluorescence staining of
RPGR-1, RPGR-3, RPGR-4 and RPGR-5 with a previously reported
CEP290 antibody demonstrated ∼50% reduction in the levels
of CEP290 at the basal body (determined by the co-localization
with basal body marker γ -tubulin) and concomitant increase in
the cytosolic CEP290 distribution when compared with RPGR-
2 or control fibroblasts (Fig. 4A and B). However, the number
of CEP290-positive cells was not affected in the mutant as
compared with the control fibroblasts (Fig. 4C). These results
are consistent with previous studies that demonstrated longer
cilia in CEP290-mutant patient fibroblasts and in Cep290-mutant
mice (38,39) and suggest an association between the observed
cilia length differences and CEP290 levels in the RPGR-mutant
fibroblasts.
Tubulin polyglutamylation is a modification of the stable cil-
iary microtubules, which can be detected using the GT335 anti-
body (40,41). We found that the distribution of GT335 was altered
in the RPGRORF15-mutant fibroblasts. Immunofluorescence anal-
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Figure 4. Distribution of ciliary markers. CEP290 (A–C) and GT335 (D–F) staining in the indicated fibroblasts was assessed. (A) The cells were stained with CEP290
(green) and γ -tubulin (basal body marker, red) antibodies and the ratio of the CEP290-positive signal in the cytoplasm to that at the basal body (B) and the number
of CEP290-positive cells (C) were quantified using ImageJ (n > 100). (D) The cells were stained with GT335 (green, glutamylated tubulin) and ARL13B (red, cilia marker).
(E) The distribution of GT335 (green signal intensity) along the length of the cilium when compared with ARL13B (red intensity) (distance, μm) was quantified using
IMARIS software (Oxford Instruments). a.u., arbitrary units.
proximal region of the cilia in RPGR-1, RPGR-3, RPGR-4 and RPGR-
5 (within ∼1.0 μm) (Fig. 4D and E) when compared with RPGR-2
and the controls, in which GT335 staining is distributed across
the whole cilium (Fig. 4F).
Expression of wild-type RPGRORF15 in mutant fibroblasts
We then sought to determine whether the observed cilia
length defects are due to the lack of the wild-type RPGRORF15
protein. Transfection of the wild-type human green fluorescent
protein (GFP)-RPGRORF15-encoding complementary DNA (cDNA)
into RPGR-3, RPGR-4 and RPGR-5 did not completely reverse
the elongated cilia phenotype when compared with cells
transfected with only GFP. Although the RPGR-3, RPGR-4 and
RPGR-5 fibroblasts transfected with GFP alone formed longer
cilia than the CTL (control) fibroblasts, the cilia length reduced
from 2.2–2.4 μm to 1.3–1.5 μm after transfection with GFP-
RPGRORF15 (Fig. 5A and B). RPGR-1, which had relatively modest
(∼1.8 μm) increase in the cilia length and RPGRex1-19/RPGRORF15
ratio showed almost complete reversal (∼1 μm) of the elongated
cilia phenotype upon GFP-RPGRORF15 expression. These data
strongly suggest that the normal RPGRORF15 protein function
partly contributes to the observed cilia length changes. Samples
with relatively higher RPGRex1-19/RPGRORF15 ratio did not show
complete reversal of the cilia length phenotype. Further support
of this hypothesis comes from the observation that expressing
RPGRORF15 in the control or RPGR-2 (∼20% longer cilia) cells
significantly reduced the cilia length 10–20% less than the
average lengths of the GFP-expressing control cells. All cells
transfected with RPGRORF15-encoding cDNA overexpressed
RPGRORF15 to similar levels (4–5-fold higher) when compared with
GFP-expressing control cells (Supplementary Fig. S3A) and did
not alter the RPGRex1-19 levels (Supplementary Fig. S3B).
Some RPGRORF15-mutant isoforms are less stable
Varying mRNA levels of the RPGR isoforms could be due to
the mutations affecting the purine-rich repeat region of the
genomic DNA or RPGR mRNA stability. As some RPGRORF15 muta-
tions (RPGR-2, RPGR-6, RPGR-7 and RPGR-8) did not affect the
isoform ratio, we concluded that the DNA architecture in the
region of those mutations is not sufficient to cause the observed
changes. We then tested whether the effect on RPGR isoform
ratio is due to changes in its stability. We performed transcrip-
tion inhibition assays using actinomycin D to assess the half-
lives of the RPGR isoforms. Our studies revealed that the mutant
RPGRORF15 levels rapidly decrease to ∼10% of the total levels
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Figure 5. Effect of wild-type RPGRORF15 overexpression on the cilia defect. (A) The fibroblasts were transiently transfected with plasmids-encoding GFP or GFP-RPGRORF15
and processed for staining with the GFP (green) or acetylated α-tubulin (red, ciliary marker). Arrows point to the ciliated cells marked in the inset in green channel.
The nuclei are stained with DAPI (blue). (B) The cilia length was quantified using ImageJ (n > 100). The graph shows the cilia length relative to the length of the control
(CTL) fibroblasts transfected with only GFP-encoding cDNA. The statistical significance of the cilia length in the GFP or GFP-RPGRORF15-transfected mutant fibroblasts
cells was determined relative to the GFP-transfected control fibroblasts. ∗∗P < 0.01; ∗∗∗P < 0.0002; ∗∗∗∗P < 0.0001; ns, not significant. Note that the GFP-RPGRORF15-
transfected RPGR-2 and CTL cells have significantly shorter cilia when compared with the GFP-transfected counterparts.
minimal levels by 4 h in RPGR-3, RPGR-4 and RPGR-5 samples.
Their levels also remained significantly lower than the control
at all time points. However, the rate of decline of the mutant
RPGRORF15 levels in RPGR-1 and RPGR-2 samples was overall sim-
ilar to that of the control RPGRORF15 mRNA. There was, how-
ever, a slightly faster decline of the mutant RPGRORF15 levels
in RPGR-1 and RPGR-2 at 6 and 8 h of actinomycin D treat-
ment when compared with the control (Fig. 6A). As predicted,
we did not detect a significant difference in the decay of the
RPGRex1-19 mRNA in the patient fibroblasts relative to the controls
(Fig. 6B). Based on these studies, we found that the half-life of
the mutant RPGRORF15 in RPGR-1 and RPGR-2 after actinomycin
D treatment relative to vehicle treatment was similar to that
in control fibroblasts (∼2.3 and 2.2 h for RPGR-1 and RPGR-2,
respectively, and 1.6 h for control) (Fig. 4C), whereas the half-
life of the mutant RPGRORF15 in RPGR-3, RPGR-4 and RPGR-5 was
0.67, 0.51 and 0.28 h, respectively. Linear regression analysis
further validated that the decay kinetics of mutant RPGRORF15 in
RPGR-3, RPGR-4 and RPGR-5 does not follow a linear correlation
(Fig. 6C).
RPGRex1-19 knockdown in mutant fibroblasts
If RPGRORF15 only partly reversed the cilia length, the increase
in the RPGRex1-19 levels could also be relevant to the observed
cilia elongation in the RPGRORF15-mutant fibroblasts. To test
this, we overexpressed RPGRex1-19 in human telomerase reverse
transcriptase-retinal pigmented epithelium (hTERT-RPE1) cells
by transient transfection. Our analysis revealed 3–4-fold longer
cilia in the RPGRex1-19 overexpressing cells as compared with the
control cells (Supplementary Fig. S4A). Thus, we hypothesized
that reducing the RPGRex1-19 levels will alleviate the elongated
cilia phenotype. To this end, we performed small interfering
ribonucleic acid (siRNA)-mediated depletion of RPGRex1-19.
We designed three siRNAs (siRNA-1, siRNA-2 and siRNA-
3) against RPGRex1-19. All siRNAs reduced the expression of
RPGRex1-19, with maximal inhibition observed with siRNA-
3 (Supplementary Fig. S4B), when compared with the levels
expressed in cells transfected with a scrambled sequence
control. Moreover, the siRNAs did not affect RPGRORF15 levels
in the fibroblasts (Supplementary Fig. S4C). Transfection of
RPGRex1-19-siRNAs followed by immunofluorescence analysis in
RPGR-3 and RPGR-5 revealed an almost complete reversal of
the cilia elongation phenotype with the cilia length comparable
with that of the scrambled siRNA-treated control fibroblasts.
RPGR-4 showed ∼90% reduction in cilia length compared with
scrambled siRNA-treated cells (Fig. 7A and B).
Discussion
Although RPGRORF15 gene augmentation therapy has been suc-
cessful in naturally occurring canine mutations and murine
models (42,43) and is currently in human clinical trials, efficacy
of the treatment across the large spectrum of human exon
ORF15 mutations is currently not known. We show that all eight
RPGRORF15 mutations tested here cause cilia length defects of
varying extents, lead to mutant mRNA instability and four muta-
tions lead to a significant increase in the RPGRex1-19/RPGRORF15
ratio. Our results indicate that three out of four exon ORF15
mutations that result in an increase in the RPGRex1-19/RPGRORF15
mRNA ratio have shorter half-life due to relatively faster mutant
mRNA decay, yet have relatively higher steady-state levels of
the mutant RPGRORF15 mRNA and protein. The precise mecha-
nism of the transcriptional complexity observed in this study
is not clear. Nonetheless, these results point to transcriptional
adaptation in which the unstable mRNA transcripts can result
in a feedback response to increase the levels of the protein.
RPGR transcriptional adaptation could increase the RPGRORF15
protein levels; however, at the same time also increase RPGRex1-19
levels, as observed in this study. Such transcriptional adapta-
tion may result from the need to compensate for the decaying
mutant RPGRORF15 transcripts (44–46); however, its relevance to
retinal disease remains to be determined. We also found that
the expression of wild-type RPGRORF15 did not affect the elevated
RPGRex1-19 levels in fibroblasts. This suggests that the mechanism
of increase in the RPGRex1-19 levels is not due to the absence of the
wild-type RPGRORF15 and implicates the expression of the mutant
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Figure 6. Mutant mRNA decay in RPGRORF15 fibroblasts. Quantitative PCR analysis of RPGRORF15 (A) or RPGRex1-19 (B) isoform was performed in fibroblasts treated with
actinomycin D for indicated time. The levels of the mutant isoforms were calculated relative to the levels in the control (CTL) fibroblasts at the same time points.
Statistical significance was determined by assessing the mRNA levels at each time point relative to that of the control (CTL) at the same time point. ∗∗∗∗P < 0.0001;
∗∗P < 0.01; ∗P < 0.05. No significant changes in the degradation of RPGRex-19 mRNA were detected at the same time points (B). (C) The half-life and linear regression of
the mutant RPGRORF15 and RPGRex1-19 mRNAs was calculated by determining the time (in hours) taken by the isoforms to reduce to half the original levels.
Figure 7. Effect of RPGRex1-19 knockdown on the cilia defect. (A) The fibroblasts were transiently transfected with RPGR-siRNA-3 or scrambled siRNA followed by GFP
(green, inset) and acetylated α-tubulin staining. (B) The cilia length was quantified represented as the length relative to the scrambled siRNA-treated control (CTL) cells.
Scale: 5 μm; ns, not significant.
other hand, seem to be due in part to the lack of the RPGRORF15
protein and to the relatively increased expression of RPGRex1-19.
This is because RPGRORF15 overexpression or RPGRex1-19 knock-
down were able to partly reverse the cilia defect, with RPGRex1-19
knockdown showing better reversal of the cilia length. These
results suggest that the relative levels of both RPGR isoforms
are critical for optimal cilia growth. Further support of this
hypothesis comes from our observation that the overexpres-
sion of RPGRex1-19 leads to longer cilia while that of RPGRORF15
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overexpression of Rpgrex1-19 or RPGRORF15 in mice results in severe
retinal degeneration (47,48).
What is the mechanism of cilia elongation in RPGRORF15-
mutant samples? We found that the imbalanced RPGRex1-19/
RPGRORF15 ratio subsequently results in higher overall levels of the
RPGR proteins. This could lead to increased context-dependent
function of RPGR-containing protein complexes at the cilia and
alteration of the gatekeeping function at the transition zone. We
previously showed that RPGR regulates the composition of the
ciliary outer segments of photoreceptors by affecting its ability
to maintain the barrier at the transition zone (30). RPGRex1-19 is
also involved in regulating ciliary cargo trafficking in cultured
cells as well as mouse photoreceptors (24). Moreover, both RPGR
isoforms interact genetically and physically with CEP290 and
this interaction is critical for photoreceptor outer segment
viability and function (24). Hence, RPGR–CEP290 interaction
could take place in overlapping as well as distinct complexes
consisting of the different isoforms. We, therefore, propose that
RPGRORF15 mutations that perturb ratio of the two isoforms and
subsequently the integrity or recruitment of the multiprotein
complexes result in altered ciliary trafficking. Further studies
are underway to delineate the mechanism of such effects.
Mutations in retinal ciliary proteins have been mostly associ-
ated with reduced cilia length and photoreceptor outer segment
degeneration. Knockdown of rpgr in zebrafish or in cultured
human RPE cell lines results in shorter cilia (49–52). Although the
fibroblasts derived from RPGRORF15 patients exhibited longer cilia,
longer photoreceptor outer segments were not observed in iPSC-
derived optic cups or in RPGR patients. These results could reflect
cell-type specific differences in the utilization of distinct cil-
iary regulation pathways. Previous clinical findings and animal
model studies also showed that RPGR mutations do not prevent
the initial generation of the photoreceptor outer segments, but
that they undergo progressive degeneration (28,29,31). Of note,
context-dependent cilia length regulation and outer segment
defects have been reported with CEP290-patient fibroblasts and
CP110-mouse fibroblasts (39,53).
The RPGR-2, RPGR-3, RPGR-4 and RPGR-5 are similar in nature
(small frameshifts), they produce profoundly different effects.
These could partly be due to the location of these mutations:
while the RPGR-2 mutation is located towards the 3′-region of
the non-repetitive exon 15, the RPGR-3, RPGR-4 and RPGR-5
mutations lie in the 5′-region of the repetitive purine-rich region.
The repetitive region of these mutations may be involved in the
recognition or recruitment of mRNA decay factors or splicing
effectors. On the other hand, the RPGR-1 mutation, which lies
within exon 15 does not show increased RPGRex1-19 levels, yet the
steady-state levels of the mutant RPGRORF15 mRNA are signifi-
cantly reduced. As the mRNA stability profile of this mutant is
similar to that of the control, there may be a different mecha-
nism underlying reduced mutant RPGRORF15 levels. However, the
resultant increase in the RPGRex1-19/RPGRORF15 ratio indicates the
similar cilia extension defect as RPGR-3, RPGR-4 and RPGR-5.
The partial effect of overexpression of RPGRORF15 in the
mutant fibroblasts on the rescue of the ciliary phenotype
potentially also raises questions that they may be relevant to the
ongoing clinical trials that utilize RPGRORF15 gene augmentation
strategy. These studies are based upon the rationale that the
RPGRORF15 mutations result in a complete or partial loss of
function. Although our study was in progress, first results of
a phase 1/2 study reported encouraging results with 7 out of
18 patients showing early improvement in visual function after
RPGRORF15 gene augmentation therapy (54). However, at least one
of the patients with the mutation c.2405_2406delAG (RPGR-3)
did not reveal reliable clinical improvement. Our results predict
that this mutation would cause a significant disruption in the
RPGR isoform ratio and abnormally longer cilia that might not
be completely reversed by RPGRORF15 overexpression. This study
underscores the complexity of RPGR gene defects and suggests
that gene therapy strategies may need to focus on ways to
restore the appropriate RPGRex1-19/RPGRORF15 ratio, taking into
account the consequences of different ORF15 mutations; ORF15
overexpression may be a less effective therapeutic strategy for
patients with certain RPGRORF15 mutations.
Materials and Methods
Study approval
The skin biopsies were obtained from previously published XLRP
patients and unaffected individuals after written informed con-
sent. All procedures followed the Declaration of Helsinki and
approved by the Institutional Review Board of the University of
Pennsylvania and UMass Medical School.
Plasmid DNA constructs and antibodies
The plasmids-encoding human RPGRORF15 or RPGRex1-19 have
been described (50,51). Antibody details are provided in
Supplementary Table S1.
Fibroblast isolation
The biopsies were dissociated as previously described to obtain
primary fibroblasts (39). Briefly, skin biopsies were washed in
iodine followed by three washes in phosphate-buffered saline
(Invitrogen). The sample was minced with a sharp scalpel in
a culture plate and incubated with Dulbecco’s-modified Eagle’s
medium (DMEM)/F12 (Invitrogen) supplemented with 20% fetal
bovine serum (FBS) (Sigma-Aldrich, Saint-Louis, MO, USA), peni-
cillin and streptomycin at 37◦C in a humidified 5% CO2 incubator.
Ten days after harvesting, the skin was removed, and fibroblasts
were passaged for storage and analysis. After dissociation, cells
were grown in DMEM/F12 media containing 10% FBS at 37◦C and
5% CO2 incubator. All analyses were done in the fibroblasts at
the same passage stages.
Fibroblast transfection assays
Plasmid DNA transfections was performed using FuGENE 6
(Promega) according to the manufacturer’s protocol. All Dicer
substrate siRNAs (RPGRex1-19, positive and negative controls, see
Supplementary Table S2) were designed and purchased from
Integrated DNA Technology and transfected at 20 nM using
Lipofectamine RNAiMAX Reagent (Thermo Fisher Scientific),
as per manufacturer’s instructions. Cells were plated and
transfected 24 h later at 50–70% confluency and induced to form
primary cilia 24 h post-transfection by serum starvation for 24 h.
RNA extraction and quantitative reverse
transcriptase-polymerase chain reaction (qRT-PCR)
analysis
Total RNAs were isolated with QIAzol Lysis Reagent (Qiagen)
and precipitated according to the manufacturer’s instructions.
Reverse transcription was performed with 1 μg of total RNAs
with the SuperScript™ First-Strand Synthesis System for RT-
PCR (Invitrogen). The resulting cDNA was used to perform gene
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and Power SYBR Green PCR Master Mix (Thermo Fisher Scien-
tific). The isoform-specific quantitative PCR (qPCR) primers are
described in Supplementary Table S2.
RNA stability assay
Messenger RNA decay after transcriptional inhibition with acti-
nomycin D treatment was performed as previously described
(55). Briefly, the fibroblasts were plated at 50% confluency in
six-well plates; 24 h later, cells were treated with 10 μg/ml
actinomycin D (Sigma-Aldrich) in DMEM/F12 media for 1, 2, 4,
6 and 8 h. Total mRNA was extracted and subjected to RT-
qPCR. Experiments were conducted in triplicates and mRNA
decay rate was determined by non-linear regression curve fitting
(one-phase decay) using GraphPad Prism Software.
Immunoblotting
The cells were lyzed on ice in Pierce RIPA Buffer (Thermo Scien-
tific) containing Halt™ Protease Inhibitor Cocktail (100X, Thermo
Fisher). Lysates were sonicated and centrifugated at 12 000g for
15 min. Supernatants were quantified and 20 μg of total protein
lysate was incubated for 5 min at 95◦C with Laemmli sample
buffer. Proteins were separated on a 4–20% Mini-PROTEAN
®
TGX™ Precast Protein Gel (BioRad) and transferred to a nitrocellu-
lose membrane (BioRad). The blots were processed using LI-COR
western blotting instructions and blocking, and primary and sec-
ondary antibodies solutions were prepared in Intercept Blocking
buffer (LI-COR). Primary antibodies were incubated overnight at
4◦C and secondary antibodies were incubated at room tempera-
ture for 2 h (see supplementary table for antibodies details and
dilution information). Protein expression was detected using LI-
COR Odyssey Fc detection system and quantified with Image
Studio Lite quantification software (LI-COR).
Immunofluorescence, microscopy and co-localization
analysis
The primary fibroblasts were plated on coverslips (AmScope
CS-R18-100) and fixed in pre-chilled 100% methanol at −20◦C
for 5 min or in 4% paraformaldehyde/1X Dulbecco’s phosphate-
buffered saline (DPBS; potassium chloride 0.2 g/L, potassium
dihydrogen phosphate 0.2 g/L, sodium chloride 8 g/L and dis-
odium hydrogen phosphate 1.15 g/L) for 10 min, washed three
times in DPBS and blocked in DPBS containing 5% normal goat
serum and 0.5% Triton X-100 for 1 h. Primary antibody solu-
tion was prepared in blocking solution and incubated overnight
at 4◦C. After washing in DPBS, cells were incubated in block-
ing solution containing Alexa-488-conjugated and Alexa-546-
conjugated (Invitrogen) for 1 h. Finally, cells were washed in DPBS
and incubated for 5 min with DAPI for nuclear staining. Cover-
slips were mounted with Antifade Mounting Media (Vectashield)
and all images were visualized over 63× objective using a Leica
DM6 Thunder microscope with a 16 bit monochrome camera.
Cilia length was measured on single z-stacks using the
ImageJ software and line and measure tool. An average of 15
cilia were measured in at least five different coverslip area using
acetylated tubulin or ADP-ribosylation factor like 13B (ARL13B)
ciliary markers. The IMARIS platform was used to process the
two channel intensities simultaneously and to measure the
degree of overlap of the two channels. After setting intensity
threshold, the basal body marker γ -tubulin was used to define
a region of interest and a co-localization channel was built
on different z-stacks to obtain the percentage of co-localized
signal and intensity. When needed, adjacent optical sections
were merged in the z-axis to form a projected image (ImageJ).
Co-localization value was plotted using the GraphPad Prism
software.
Statistics
All data are presented as means ± standard derivation from the
mean. Two groups comparison was analyzed by Student’s t-tests
using the Prism GraphPad software. Multiple groups compari-
son was performed with one-way analysis of variance. Differ-
ences between groups were considered statistically significant
if P < 0.05. The statistical significance is denoted with asterisks
(∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.005; ∗∗∗∗P < 0.001).
Supplementary Material
Supplementary Material is available at HMG online.
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